The new market reality, multichannel marketing and pharma’s biggest brands

Closing an issue of the magazine the day your youngest son wakes at 4am with growing pains and can’t get back to sleep is not necessarily to be recommended, but we got there in the end and put together another good looking issue.

This month’s PME (Pharmaceutical Market Europe) features an exclusive interview with MSD’s president, Europe and Canada Bruno Strigini on pharma’s new market reality.

We also spoke with Janssen’s company group chairman responsible for the EMEA region Jane Griffiths and EFPIA’s chairman Richard Bergstrom on how they would like the industry to be seen.